HEADER TRANSFERASE 17-DEC-18 6NEC TITLE STRUCTURE OF RET PROTEIN TYROSINE KINASE DOMAIN IN COMPLEX WITH TITLE 2 NINTEDANIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CADHERIN FAMILY MEMBER 12,PROTO-ONCOGENE C-RET; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RET, CDHF12, CDHR16, PTC, RET51; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBACPAK6 KEYWDS TRANSFERASE, ONCOGENE, RET, TYROSINE KINASE, ATP-BINDING, THYROID KEYWDS 2 CANCER, NON-SMALL CELL LUNG CANCER, NINTEDANIB, COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.S.TERZYAN,T.SHEN,J.WU,B.H.M.MOOERS REVDAT 5 11-OCT-23 6NEC 1 REMARK REVDAT 4 18-DEC-19 6NEC 1 REMARK REVDAT 3 25-SEP-19 6NEC 1 REMARK REVDAT 2 17-JUL-19 6NEC 1 JRNL REVDAT 1 05-JUN-19 6NEC 0 JRNL AUTH S.S.TERZYAN,T.SHEN,X.LIU,Q.HUANG,P.TENG,M.ZHOU,F.HILBERG, JRNL AUTH 2 J.CAI,B.H.M.MOOERS,J.WU JRNL TITL STRUCTURAL BASIS OF RESISTANCE OF MUTANT RET JRNL TITL 2 PROTEIN-TYROSINE KINASE TO ITS INHIBITORS NINTEDANIB AND JRNL TITL 3 VANDETANIB. JRNL REF J.BIOL.CHEM. V. 294 10428 2019 JRNL REFN ESSN 1083-351X JRNL PMID 31118272 JRNL DOI 10.1074/JBC.RA119.007682 REMARK 2 REMARK 2 RESOLUTION. 1.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 47593 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2483 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.87 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.92 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2914 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.45 REMARK 3 BIN R VALUE (WORKING SET) : 0.2910 REMARK 3 BIN FREE R VALUE SET COUNT : 151 REMARK 3 BIN FREE R VALUE : 0.3330 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4565 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 241 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.160 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.145 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.109 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.702 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4879 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6601 ; 1.323 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 594 ; 5.179 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 212 ;35.880 ;23.443 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 885 ;14.049 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;17.118 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 698 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3693 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2346 ; 2.008 ; 3.880 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2947 ; 3.226 ; 5.790 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2533 ; 2.497 ; 4.198 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 7759 ; 7.971 ;33.142 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6NEC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-DEC-18. REMARK 100 THE DEPOSITION ID IS D_1000238649. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAY-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE CRYSTAL REMARK 200 OPTICS : FLAT BENT COLLIMATING RH COATED REMARK 200 MIRROR, TOROIDAL FOCUSSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50094 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870 REMARK 200 RESOLUTION RANGE LOW (A) : 78.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.2 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.39700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2IVT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.6 M NA FORMATE 0.1M NA CITRATE REMARK 280 PH5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.14750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 700 REMARK 465 PRO A 701 REMARK 465 LEU A 702 REMARK 465 SER A 703 REMARK 465 LEU A 704 REMARK 465 SER A 705 REMARK 465 VAL A 706 REMARK 465 ASP A 707 REMARK 465 ALA A 708 REMARK 465 PHE A 709 REMARK 465 LYS A 710 REMARK 465 ILE A 711 REMARK 465 LEU A 712 REMARK 465 SER A 829 REMARK 465 GLY A 830 REMARK 465 GLY A 831 REMARK 465 SER A 832 REMARK 465 ARG A 833 REMARK 465 ASN A 834 REMARK 465 SER A 835 REMARK 465 SER A 836 REMARK 465 SER A 837 REMARK 465 LEU A 838 REMARK 465 ASP A 839 REMARK 465 HIS A 840 REMARK 465 PRO A 841 REMARK 465 ARG A 1013 REMARK 465 GLY C 823 REMARK 465 PRO C 824 REMARK 465 GLY C 825 REMARK 465 TYR C 826 REMARK 465 LEU C 827 REMARK 465 GLY C 828 REMARK 465 SER C 829 REMARK 465 GLY C 830 REMARK 465 GLY C 831 REMARK 465 SER C 832 REMARK 465 ARG C 833 REMARK 465 ASN C 834 REMARK 465 SER C 835 REMARK 465 SER C 836 REMARK 465 SER C 837 REMARK 465 LEU C 838 REMARK 465 ASP C 839 REMARK 465 HIS C 840 REMARK 465 PRO C 841 REMARK 465 ASP C 842 REMARK 465 TYR C 900 REMARK 465 GLU C 901 REMARK 465 GLU C 902 REMARK 465 ASP C 903 REMARK 465 SER C 904 REMARK 465 TYR C 905 REMARK 465 VAL C 906 REMARK 465 LYS C 907 REMARK 465 ARG C 908 REMARK 465 ARG C 1013 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG C 820 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 821 CG CD CE NZ REMARK 470 GLU C 843 CG CD OE1 OE2 REMARK 470 LYS C1011 CG CD CE NZ REMARK 470 ARG C1012 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 797 39.23 -94.87 REMARK 500 ARG A 873 -24.66 74.89 REMARK 500 ASP A 892 71.58 60.89 REMARK 500 TYR A 900 -59.44 -26.57 REMARK 500 GLU A 902 -6.59 76.05 REMARK 500 ASN A 975 46.77 -95.51 REMARK 500 ASP C 714 88.92 48.75 REMARK 500 ARG C 873 -28.28 83.36 REMARK 500 ASP C 892 73.50 57.73 REMARK 500 MET C1008 34.74 -87.37 REMARK 500 MET C1009 -30.12 -133.75 REMARK 500 LYS C1011 32.67 -97.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue XIN A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMT A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMT C 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue XIN C 1102 DBREF 6NEC A 705 1013 UNP P07949 RET_HUMAN 705 1013 DBREF 6NEC C 705 1013 UNP P07949 RET_HUMAN 705 1013 SEQADV 6NEC GLY A 700 UNP P07949 EXPRESSION TAG SEQADV 6NEC PRO A 701 UNP P07949 EXPRESSION TAG SEQADV 6NEC LEU A 702 UNP P07949 EXPRESSION TAG SEQADV 6NEC SER A 703 UNP P07949 EXPRESSION TAG SEQADV 6NEC LEU A 704 UNP P07949 EXPRESSION TAG SEQADV 6NEC GLY C 700 UNP P07949 EXPRESSION TAG SEQADV 6NEC PRO C 701 UNP P07949 EXPRESSION TAG SEQADV 6NEC LEU C 702 UNP P07949 EXPRESSION TAG SEQADV 6NEC SER C 703 UNP P07949 EXPRESSION TAG SEQADV 6NEC LEU C 704 UNP P07949 EXPRESSION TAG SEQRES 1 A 314 GLY PRO LEU SER LEU SER VAL ASP ALA PHE LYS ILE LEU SEQRES 2 A 314 GLU ASP PRO LYS TRP GLU PHE PRO ARG LYS ASN LEU VAL SEQRES 3 A 314 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY LYS VAL SEQRES 4 A 314 VAL LYS ALA THR ALA PHE HIS LEU LYS GLY ARG ALA GLY SEQRES 5 A 314 TYR THR THR VAL ALA VAL LYS MET LEU LYS GLU ASN ALA SEQRES 6 A 314 SER PRO SER GLU LEU ARG ASP LEU LEU SER GLU PHE ASN SEQRES 7 A 314 VAL LEU LYS GLN VAL ASN HIS PRO HIS VAL ILE LYS LEU SEQRES 8 A 314 TYR GLY ALA CYS SER GLN ASP GLY PRO LEU LEU LEU ILE SEQRES 9 A 314 VAL GLU TYR ALA LYS TYR GLY SER LEU ARG GLY PHE LEU SEQRES 10 A 314 ARG GLU SER ARG LYS VAL GLY PRO GLY TYR LEU GLY SER SEQRES 11 A 314 GLY GLY SER ARG ASN SER SER SER LEU ASP HIS PRO ASP SEQRES 12 A 314 GLU ARG ALA LEU THR MET GLY ASP LEU ILE SER PHE ALA SEQRES 13 A 314 TRP GLN ILE SER GLN GLY MET GLN TYR LEU ALA GLU MET SEQRES 14 A 314 LYS LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU SEQRES 15 A 314 VAL ALA GLU GLY ARG LYS MET LYS ILE SER ASP PHE GLY SEQRES 16 A 314 LEU SER ARG ASP VAL TYR GLU GLU ASP SER TYR VAL LYS SEQRES 17 A 314 ARG SER GLN GLY ARG ILE PRO VAL LYS TRP MET ALA ILE SEQRES 18 A 314 GLU SER LEU PHE ASP HIS ILE TYR THR THR GLN SER ASP SEQRES 19 A 314 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE VAL THR SEQRES 20 A 314 LEU GLY GLY ASN PRO TYR PRO GLY ILE PRO PRO GLU ARG SEQRES 21 A 314 LEU PHE ASN LEU LEU LYS THR GLY HIS ARG MET GLU ARG SEQRES 22 A 314 PRO ASP ASN CYS SER GLU GLU MET TYR ARG LEU MET LEU SEQRES 23 A 314 GLN CYS TRP LYS GLN GLU PRO ASP LYS ARG PRO VAL PHE SEQRES 24 A 314 ALA ASP ILE SER LYS ASP LEU GLU LYS MET MET VAL LYS SEQRES 25 A 314 ARG ARG SEQRES 1 C 314 GLY PRO LEU SER LEU SER VAL ASP ALA PHE LYS ILE LEU SEQRES 2 C 314 GLU ASP PRO LYS TRP GLU PHE PRO ARG LYS ASN LEU VAL SEQRES 3 C 314 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY LYS VAL SEQRES 4 C 314 VAL LYS ALA THR ALA PHE HIS LEU LYS GLY ARG ALA GLY SEQRES 5 C 314 TYR THR THR VAL ALA VAL LYS MET LEU LYS GLU ASN ALA SEQRES 6 C 314 SER PRO SER GLU LEU ARG ASP LEU LEU SER GLU PHE ASN SEQRES 7 C 314 VAL LEU LYS GLN VAL ASN HIS PRO HIS VAL ILE LYS LEU SEQRES 8 C 314 TYR GLY ALA CYS SER GLN ASP GLY PRO LEU LEU LEU ILE SEQRES 9 C 314 VAL GLU TYR ALA LYS TYR GLY SER LEU ARG GLY PHE LEU SEQRES 10 C 314 ARG GLU SER ARG LYS VAL GLY PRO GLY TYR LEU GLY SER SEQRES 11 C 314 GLY GLY SER ARG ASN SER SER SER LEU ASP HIS PRO ASP SEQRES 12 C 314 GLU ARG ALA LEU THR MET GLY ASP LEU ILE SER PHE ALA SEQRES 13 C 314 TRP GLN ILE SER GLN GLY MET GLN TYR LEU ALA GLU MET SEQRES 14 C 314 LYS LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU SEQRES 15 C 314 VAL ALA GLU GLY ARG LYS MET LYS ILE SER ASP PHE GLY SEQRES 16 C 314 LEU SER ARG ASP VAL TYR GLU GLU ASP SER TYR VAL LYS SEQRES 17 C 314 ARG SER GLN GLY ARG ILE PRO VAL LYS TRP MET ALA ILE SEQRES 18 C 314 GLU SER LEU PHE ASP HIS ILE TYR THR THR GLN SER ASP SEQRES 19 C 314 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE VAL THR SEQRES 20 C 314 LEU GLY GLY ASN PRO TYR PRO GLY ILE PRO PRO GLU ARG SEQRES 21 C 314 LEU PHE ASN LEU LEU LYS THR GLY HIS ARG MET GLU ARG SEQRES 22 C 314 PRO ASP ASN CYS SER GLU GLU MET TYR ARG LEU MET LEU SEQRES 23 C 314 GLN CYS TRP LYS GLN GLU PRO ASP LYS ARG PRO VAL PHE SEQRES 24 C 314 ALA ASP ILE SER LYS ASP LEU GLU LYS MET MET VAL LYS SEQRES 25 C 314 ARG ARG HET XIN A1101 40 HET FMT A1102 3 HET FMT C1101 3 HET XIN C1102 40 HETNAM XIN METHYL (3Z)-3-{[(4-{METHYL[(4-METHYLPIPERAZIN-1-YL) HETNAM 2 XIN ACETYL]AMINO}PHENYL)AMINO](PHENYL)METHYLIDENE}-2-OXO- HETNAM 3 XIN 2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLATE HETNAM FMT FORMIC ACID FORMUL 3 XIN 2(C31 H33 N5 O4) FORMUL 4 FMT 2(C H2 O2) FORMUL 7 HOH *241(H2 O) HELIX 1 AA1 PRO A 720 LYS A 722 5 3 HELIX 2 AA2 LEU A 746 ARG A 749 5 4 HELIX 3 AA3 SER A 765 VAL A 782 1 18 HELIX 4 AA4 SER A 811 ARG A 820 1 10 HELIX 5 AA5 THR A 847 MET A 868 1 22 HELIX 6 AA6 ALA A 876 ARG A 878 5 3 HELIX 7 AA7 GLU A 884 ARG A 886 5 3 HELIX 8 AA8 PRO A 914 MET A 918 5 5 HELIX 9 AA9 ALA A 919 HIS A 926 1 8 HELIX 10 AB1 THR A 929 THR A 946 1 18 HELIX 11 AB2 PRO A 956 GLU A 958 5 3 HELIX 12 AB3 ARG A 959 THR A 966 1 8 HELIX 13 AB4 SER A 977 TRP A 988 1 12 HELIX 14 AB5 GLU A 991 ARG A 995 5 5 HELIX 15 AB6 VAL A 997 LYS A 1011 1 15 HELIX 16 AB7 PRO C 701 ILE C 711 1 11 HELIX 17 AB8 PRO C 720 LYS C 722 5 3 HELIX 18 AB9 LEU C 746 ARG C 749 5 4 HELIX 19 AC1 SER C 765 LYS C 780 1 16 HELIX 20 AC2 SER C 811 SER C 819 1 9 HELIX 21 AC3 THR C 847 MET C 868 1 22 HELIX 22 AC4 ALA C 876 ARG C 878 5 3 HELIX 23 AC5 PRO C 914 MET C 918 5 5 HELIX 24 AC6 ALA C 919 HIS C 926 1 8 HELIX 25 AC7 THR C 929 THR C 946 1 18 HELIX 26 AC8 PRO C 956 GLU C 958 5 3 HELIX 27 AC9 ARG C 959 THR C 966 1 8 HELIX 28 AD1 SER C 977 TRP C 988 1 12 HELIX 29 AD2 GLU C 991 ARG C 995 5 5 HELIX 30 AD3 VAL C 997 LYS C 1011 1 15 SHEET 1 AA1 5 LEU A 724 GLU A 732 0 SHEET 2 AA1 5 GLY A 736 PHE A 744 -1 O VAL A 738 N LEU A 730 SHEET 3 AA1 5 TYR A 752 LEU A 760 -1 O VAL A 757 N VAL A 739 SHEET 4 AA1 5 LEU A 801 VAL A 804 -1 O VAL A 804 N ALA A 756 SHEET 5 AA1 5 LEU A 790 CYS A 794 -1 N TYR A 791 O ILE A 803 SHEET 1 AA2 2 GLY A 825 TYR A 826 0 SHEET 2 AA2 2 ALA A 845 LEU A 846 1 O LEU A 846 N GLY A 825 SHEET 1 AA3 2 LEU A 870 VAL A 871 0 SHEET 2 AA3 2 ARG A 897 ASP A 898 -1 O ARG A 897 N VAL A 871 SHEET 1 AA4 2 ILE A 880 ALA A 883 0 SHEET 2 AA4 2 LYS A 887 ILE A 890 -1 O LYS A 887 N ALA A 883 SHEET 1 AA5 2 TYR A 905 VAL A 906 0 SHEET 2 AA5 2 ILE A 927 TYR A 928 -1 O TYR A 928 N TYR A 905 SHEET 1 AA6 5 LEU C 724 GLU C 732 0 SHEET 2 AA6 5 LYS C 737 PHE C 744 -1 O LYS C 740 N GLY C 727 SHEET 3 AA6 5 TYR C 752 MET C 759 -1 O THR C 753 N ALA C 743 SHEET 4 AA6 5 LEU C 801 GLU C 805 -1 O VAL C 804 N ALA C 756 SHEET 5 AA6 5 LEU C 790 CYS C 794 -1 N GLY C 792 O ILE C 803 SHEET 1 AA7 2 ARG C 820 LYS C 821 0 SHEET 2 AA7 2 ALA C 845 LEU C 846 1 O LEU C 846 N ARG C 820 SHEET 1 AA8 2 LEU C 870 VAL C 871 0 SHEET 2 AA8 2 ARG C 897 ASP C 898 -1 O ARG C 897 N VAL C 871 SHEET 1 AA9 2 ILE C 880 VAL C 882 0 SHEET 2 AA9 2 MET C 888 ILE C 890 -1 O LYS C 889 N LEU C 881 SITE 1 AC1 14 GLY A 731 ALA A 756 LYS A 758 GLU A 775 SITE 2 AC1 14 LEU A 779 ILE A 788 VAL A 804 GLU A 805 SITE 3 AC1 14 TYR A 806 ALA A 807 LYS A 808 GLY A 810 SITE 4 AC1 14 LEU A 881 ASP A 892 SITE 1 AC2 6 ARG A 873 LEU A 895 ARG A 897 LYS A 907 SITE 2 AC2 6 GLY A 911 ARG A 912 SITE 1 AC3 8 GLN A 910 LEU A 923 PHE A 924 HIS A 926 SITE 2 AC3 8 GLY C 700 PRO C 701 LEU C 702 SER C 703 SITE 1 AC4 19 THR C 729 LEU C 730 GLY C 731 VAL C 738 SITE 2 AC4 19 ALA C 756 LYS C 758 GLU C 775 LEU C 779 SITE 3 AC4 19 ILE C 788 VAL C 804 GLU C 805 TYR C 806 SITE 4 AC4 19 ALA C 807 LYS C 808 TYR C 809 GLY C 810 SITE 5 AC4 19 LEU C 881 SER C 891 ASP C 892 CRYST1 50.587 80.295 79.926 90.00 100.52 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019768 0.000000 0.003671 0.00000 SCALE2 0.000000 0.012454 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012725 0.00000